Apollo Hospitals Celebrates 25 Years of India’s First Liver Transplant Program

Apollo Hospitals pioneered India’s first successful liver transplant in 1998. The first liver transplant patient, who was 20 months old at the time, is now a doctor. Apollo Hospitals has played a leading role in positioning India as a global leader in organ transplantation

NEW DELHI, Nov. 16, 2023 /PRNewswire/ — Apollo, the world’s largest integrated healthcare provider, completed 25 years of liver transplant program in India with over 4300 liver transplants, including 515 in children from over 50 countries. Today, Apollo performs more than 1600 solid organ transplants a year. With 90% success rates, The Apollo Liver Transplant program is a beacon of quality and hope for patients from across the world.


(Left to right)) Dr. Sanjay Kandaswamy (India’s first LT patient who is now a doctor), Dr. Anupam Sibal, Ms. Dimple Kapadia, Baby Prisha with her parent, Mr. Shivakumar Pattabhiraman, Dr. Neerav Goyal

Dr. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group, said, “At Apollo, our dedication lies in ensuring that no individual succumbs due to a lack of access to transplantation. Our focus involves establishing top-tier transplant centres, led by esteemed clinicians. We are committed to extending our expertise to individuals worldwide seeking liver transplant services.”

Dr. Anupam Sibal, Group Medical Director & Senior Pediatric Gastroenterologist, said, “In the last 25 years, the liver transplant program at Apollo Institutes has achieved remarkable milestone giving hope to patients with end-stage liver diseases. Sanjay Kandasamy, India’s first liver transplant recipient is now a successful doctor, a beacon of hope for those with no hope. Success stories of our patients have encouraged us to create the most advanced transplant ecosystem, performing complex transplants such as ABO incompatible, combined liver-kidney transplants, and in babies weighing just 4 kgs.”

Dr. Neerav Goyal, Sr. Consultant, Liver Transplants, said, “With a remarkable 90% success rate, Apollo’s liver transplant program embodies unwavering commitment, serving as a beacon of hope for liver failure patients. Our intent is to expand further, extending renewed chances for a healthier life.”

The Apollo Transplant program is one of the world’s largest and most comprehensive transplant programs that manages wide range of liver disease and kidney disease, liver and kidney transplantation, heart and lung transplantation, intestinal, pancreas and GI transplant surgeries and podiatric transplant services.

About Indraprastha Apollo Hospitals:

Established in July 1996, Indraprastha Apollo Hospitals, India’s inaugural JCI accredited hospital, is a collaborative effort between the Delhi Government and Apollo Hospitals Enterprise Limited. Spanning 15 acres, it stands as the third super-specialty tertiary care facility by the Apollo Hospitals Group. Boasting 57 specialties, over 300 specialists, and 700 operational beds, the hospital is equipped with 19 operation theatres, 138 ICU beds, 24-hour emergency services, and an air ambulance. A trailblazer in kidney and liver transplants, it witnessed India’s first successful pediatric and adult liver transplants. Renowned for cutting-edge medical technology, including 64-slice CT, 3 Tesla MRI, Novalis Tx, and integrated PET Suite, the hospital leads in diagnostic, medical, and surgical facilities. With decades of satisfied clientele, Indraprastha Apollo remains at the forefront of healthcare excellence.

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.